NCT04802629

Brief Summary

The aim of this study is to investigate the relationship between cerebral and peripheral oxygenation and oxygen extraction, as measured by NIRS (near-infrared spectroscopy ), and the FHbF (fraction of fetal hemoglobin) and absolute HbF (fetal hemoglobin) concentration in postnatal conditions in term and preterm neonates.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 8, 2020

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 15, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 17, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2024

Completed
Last Updated

July 3, 2024

Status Verified

July 1, 2024

Enrollment Period

3.8 years

First QC Date

March 15, 2021

Last Update Submit

July 2, 2024

Conditions

Keywords

Fetal hemoglobinpreterm neonateterm neonatenear-infrared spectroscopycerebral oxygenationperipheral oxygenationfractional tissue oxygen extraction

Outcome Measures

Primary Outcomes (6)

  • FHbF (%)

    Fraction of fetal hemoglobin in percentage

    First two weeks after birth

  • HbF (g/dL)

    Fetal hemoglobin concentration in g/dL

    First two weeks after birth

  • Change of cTOI

    cerebral tissue oxygenation index (cTOI)

    at specific time points (2nd-3rd 6th-8th, 12th-14th day after birth)

  • Change of pTOI

    peripheral tissue oxygenation index (pTOI)

    at specific time points (2nd-3rd 6th-8th, 12th-14th day after birth)

  • Change of cFTOE

    cerebral fractional tissue oxygen extraction (cFTOE)

    at specific time points (2nd-3rd 6th-8th, 12th-14th day after birth)

  • Change of pFTOE

    peripheral fractional tissue oxygen extraction (pFTOE)

    at specific time points (2nd-3rd 6th-8th, 12th-14th day after birth)

Study Arms (2)

Term neonates

≥ 37+0 weeks of gestation

Device: Near-infrared spectroscopy

Preterm neonates

≤ 36+6 weeks of gestation

Device: Near-infrared spectroscopy

Interventions

For NIRS measurements the t-NIRS 1 and NIRO 200 NX (Hamamatsu, Japan) will be used. A cerebral sensor will be placed and fixed with a CPAP (Continuous Positive Airway Pressure) cap on the left forehead and a peripheral sensor on the right forearm. Duration of measurement will be two hours.

Preterm neonatesTerm neonates

Eligibility Criteria

Age2 Days - 3 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Preterm neonates (≤ 36+6 weeks of gestation) and term neonates (≥ 37+0 weeks of gestation) admitted to the NICU.

You may qualify if:

  • Term and preterm neonates admitted to the neonatal intensive care unit (NICU)
  • Decision to conduct full life support
  • Written informed consent

You may not qualify if:

  • No decision to conduct full life support
  • No written informed consent
  • Congenital malformations
  • Family history of haemoglobinopathies (e.g. sickle cell anaemia, thalassaemia)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Pediatrics, Division of Neonatology, Medical University of Graz

Graz, Styria, 8036, Austria

Location

MeSH Terms

Conditions

Premature Birthbeta-Thalassemia

Interventions

Spectroscopy, Near-Infrared

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesThalassemiaAnemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisSpectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Gerhard Pichler, Prof

    Medical University of Graz

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
3 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2021

First Posted

March 17, 2021

Study Start

June 8, 2020

Primary Completion

March 22, 2024

Study Completion

March 22, 2024

Last Updated

July 3, 2024

Record last verified: 2024-07

Locations